Advisory Committee on Non-prescription Medicines (ACNM)
25 November 2013
The Advisory Committee on Non-prescription Medicines (ACNM) was formed in January 2010. The ACNM advise and make recommendations to the TGA regarding the entry of non-prescription medicines on the Australian Register of Therapeutic Goods (the Register). This includes:
- inclusion of a non-prescription medicine on the Register
- changes to an entry of a non-prescription medicine on the Register
- removal or retention of a non-prescription medicine on the Register.
ACNM may also provide advice to the TGA on other matters concerning a non-prescription medicine, and any other matters referred to it by the TGA.
The ACNM supersedes the Medicines Evaluation Committee (MEC).
Mr David Newgreen was appointed as chair of the Advisory Committee on Non-prescription Medicines from 2011 after having been a member of the committee and its predecessor, the Medicines Evaluation Committee, since 1999. He is a registered pharmacist, working part-time at the Victorian Pharmacy Authority and in community pharmacy and holds many Honorary Associate Fellow and Lecturer positions. He lectures on drug control at several universities and has published on the subject. He was formerly president of the Victorian branch of the Pharmaceutical Society of Australia and has held several other significant pharmaceutical-related positions in the Department of Health, Victoria. Mr Newgreen provides expertise in the field of community pharmacy.
- Dr Geraldine Elliot is an Associate Lecturer at the University of Queensland, School of Pharmacy, lecturing in product development including formulation and physical/chemical testing of medicines. She is also the research and development Director of a company that licenses its drug delivery technology to overseas companies. Dr Elliott is a registered pharmacist and provides expertise in pharmaceutical chemistry, biopharmaceutics and clinical pharmacology.
- Professor Joan Faoagali is an Adjunct Professor within the Department of Microbiology at the University of Queensland, and is an Adjunct Professor at Griffith University. Professor Faoagali has extensive experience in medical (clinical) microbiology and infection control issues. Professor Faoagali provides expertise in medical microbiology.
- Dr Peter Goldswain had been an Associate Clinical Professor of Medicine, University of Western Australia and a consultant Geriatrician at Royal Perth Hospital (RPH) from 1978-2009. He is the immediate past Chairman of the Royal Perth Hospital’s Drug and Therapeutics Committee. Dr Goldswain was Clinical Advisor on Geriatrics to the Health Department of Western Australia from 2000-2008 and now advises the Department and Silver Chain Organisation on Residential Care options. He provides extensive expertise in specialist medical practice (geriatric medicine.)
- Associate Professor John Gullotta AM is a General Practitioner and a registered pharmacist. He is an Adjunct Associate Professor at the Sydney Medical School, at the University of Sydney. He serves on numerous Medical and Pharmaceutical advisory bodies, is a member of the Advisory Committee on Medicine Scheduling, and is past Chair of the Federal Australian Medical Association Therapeutics Committee. He provides extensive expertise in general medical practice.
- Professor Henry Kilham is a senior staff specialist at the Children's Hospital at Westmead, working in general paediatric medicine and clinical ethics. He is also an Adjunct Associate Professor at the University of Sydney and is an Associate in the Department of Values, Law and Ethics in Medicine of that university. He provides extensive expertise in specialist medical practice (paediatric medicine) and clinical toxicology.
- Dr Maureen Mitchell has worked as a General Practitioner in a wide range of clinical settings, including Indigenous Health Services in remote settings within the Northern Territory, and has a Masters in Public Health. Dr Mitchell has been a committee member of the Schedule 8 and Restricted Schedule 4 Substances Clinical Advisory Committee for the Northern Territory Government. She has a strong interest in disadvantaged health settings and palliative care. Dr Mitchell provides expertise in the field of general medical practice.
- Mrs Debra Petrys has worked in public health for over 30 years and has extensive understanding of consumer issues relating to safety and quality use of medicines. She has developed and implemented a large number of consumer health and community support programs at both the state and national level, including working as the National General Manager for the Seniors Quality Use of Medicine Consumer Program for over eight years. She currently works as a consultant on health policy and consumer participation. Mrs Petrys provides expertise in consumer issues.
- Dr Lisa Pont is a Senior Lecturer in Pharmacology and Clinical Pharmacy at the Sydney Nursing School, University of Sydney. She is a registered pharmacist, with experience in both hospital and community pharmacy in NSW and Tasmania. Dr Pont provides expertise in hospital and community pharmacy practice.
- Emeritus Professor Barry Reed holds an honorary position within the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University (Parkville campus). He is a registered pharmacist, past president of the Pharmacy Board of Victoria and a long standing member of the Advisory Committee on Non-prescription Medicines and its predecessor, the Medicines Evaluation Committee. Professor Reed provides extensive expertise in pharmaceutics, biopharmaceutics, pharmacology and pharmaceutical chemistry.
- Mr George Rook has had long experience as a senior manufacturing executive in a variety of manufacturing operations, including the corporation pharmaceutical business. Mr Rook has a degree in organic chemistry and provides expertise in the manufacture of medicines.
- Professor Andrew Somogyi is a Professor in Clinical and Experimental Pharmacology at the School of Medical Sciences, Faculty of Health Sciences at the University of Adelaide. He is a member of the Editorial Advisory Board of the Australian Medicines Handbook. He is also a registered pharmacist, and provides extensive expertise in toxicology, clinical pharmacology, pharmacogenetics, pharmacokinetics and drug metabolism.
|Cut-off date for pre-ACNM response from Sponsor||Date agenda dispatched to members||Meeting date||Venue|
|COB 19 February 2013||21 February 2013||7 March 2013||Canberra|
|COB 21 May 2013||23 May 2013||6 June 2013 (cancelled)||Canberra|
|COB 20 August 2013||22 August 2013||5 September 2013||Canberra|
|COB 19 November 2013||21 November 2013||5 December 2013 (cancelled)||Canberra|
The TGA finalises and sends evaluation reports to sponsors one month prior to the scheduled meeting date.
To contact the Advisory Committee on Non-prescription Medicines Secretary:
|Phone||+61 2 6232 8024|
|Fax||+61 2 6203 1250|
|Postal address||The Advisory Committee on Non-prescription Medicines
Therapeutic Goods Administration
PO Box 100 (MDP 122)
Woden ACT 2606
Content last updated: Monday, 25 November 2013
Content last reviewed: Monday, 25 November 2013
Web page last updated: Monday, 25 November 2013